Back to Search Start Over

Effects of Gαi 2 and Gαz protein knockdown on alpha 2A -adrenergic and cannabinoid CB 1 receptor regulation of MEK-ERK and FADD pathways in mouse cerebral cortex.

Authors :
Ramos-Miguel A
Sánchez-Blázquez P
García-Sevilla JA
Source :
Pharmacological reports : PR [Pharmacol Rep] 2021 Aug; Vol. 73 (4), pp. 1122-1135. Date of Electronic Publication: 2021 Feb 28.
Publication Year :
2021

Abstract

Background: Alpha <subscript>2A</subscript> -adrenergic (α <subscript>2A</subscript> -AR) and cannabinoid CB <subscript>1</subscript> (CB <subscript>1</subscript> -R) receptors exert their functions modulating multiple signaling pathways, including MEK-ERK (extracellular signal-regulated kinases) and FADD (Fas-associated protein with death domain) cascades. These molecules are relevant in finding biased agonists with fewer side effects, but the mechanisms involving their modulations by α <subscript>2A</subscript> -AR- and CB <subscript>1</subscript> -R in vivo are unclear. This study investigated the roles of Gαi <subscript>2</subscript> and Gαz proteins in mediating α <subscript>2A</subscript> -AR- and CB <subscript>1</subscript> -R-induced alterations of MEK-ERK and FADD phosphorylation (p-) in mouse brain cortex.<br />Methods: Gαi <subscript>2</subscript> or Gαz protein knockdown was induced in mice with selective antisense oligodeoxinucleotides (ODNs; 3 nmol/day, 5 days) prior to UK-14,304 (UK or brimonidine; 1 mg/kg) or WIN55212-2 (WIN; 8 mg/kg) acute treatments. Inactivated (p-T <superscript>286</superscript> ) MEK1, activated (p-S <superscript>217/221</superscript> ) MEK1/2, activated (p-T <superscript>202</superscript> /Y <superscript>204</superscript> ) ERK1/2, p-S <superscript>191</superscript> FADD, and the corresponding total forms of these proteins were quantified by immunoblotting.<br />Results: Increased (+ 88%) p-T <superscript>286</superscript> MEK1 cortical density, with a concomitant reduction (-43%) of activated ERK was observed in UK-treated mice. Both effects were attenuated by Gαi <subscript>2</subscript> or Gαz antisense ODNs. Contrastingly, WIN induced Gαi <subscript>2</subscript> - and Gαz-independent upregulations of p-T <superscript>286</superscript> MEK1 (+ 63%), p-S <superscript>217/221</superscript> MEK1/2 (+ 86%), and activated ERK (+ 111%) in brain. Pro-apoptotic FADD was downregulated (- 34 to 39%) following UK and WIN administration, whereas the neuroprotective p-S <superscript>191</superscript> FADD was increased (+ 74%) in WIN-treated mice only. None of these latter effects required from Gαi <subscript>2</subscript> or Gαz protein integrity.<br />Conclusion: The results indicate that α <subscript>2A</subscript> -AR (UK), but not CB <subscript>1</subscript> -R (WIN), agonists use Gαi <subscript>2</subscript> and Gαz proteins to modulate MEK-ERK, but not FADD, pathway in mouse brain cortex.<br /> (© 2021. Maj Institute of Pharmacology Polish Academy of Sciences.)

Details

Language :
English
ISSN :
2299-5684
Volume :
73
Issue :
4
Database :
MEDLINE
Journal :
Pharmacological reports : PR
Publication Type :
Academic Journal
Accession number :
33641090
Full Text :
https://doi.org/10.1007/s43440-021-00240-4